Back to top

medical-devices: Archive

Zacks Equity Research

Here's Why You Should Hold on to Catalent (CTLT) Stock Now

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.

MCKPositive Net Change PDCONegative Net Change AMNNegative Net Change CTLTNegative Net Change

Zacks Equity Research

Teleflex (TFX) Hit by Urolift Volume Decline, Cost Pressure

In the Americas, growth within the Surgical business of Teleflex (TFX) is offset by a decline in Interventional Urology.

MOHPositive Net Change PDCONegative Net Change TFXNegative Net Change AMNNegative Net Change

Zacks Equity Research

Haemonetics (HAE) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about Haemonetics' (HAE) potential in its Plasma franchise.

MDTNegative Net Change HAEPositive Net Change PDCONegative Net Change AMNNegative Net Change

Zacks Equity Research

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

MCKPositive Net Change PKINegative Net Change PDCONegative Net Change AMNNegative Net Change

Zacks Equity Research

Do Options Traders Know Something About BellRing Brands (BRBR) Stock We Don't?

Investors need to pay close attention to BellRing Brands (BRBR) stock based on the movements in the options market lately.

BRBRPositive Net Change

Sheraz Mian

Top Analyst Reports for JPMorgan Chase, AbbVie & Abbott

Today's Research Daily features new research reports on 12 major stocks, including JPMorgan Chase & Co. (JPM), AbbVie Inc. (ABBV) and Abbott Laboratories (ABT).

JPMNegative Net Change ABTPositive Net Change CATNegative Net Change INTUNegative Net Change ABBVPositive Net Change LINNegative Net Change

Zacks Equity Research

Edwards Lifesciences (EW) Gets CE Mark for PASCAL Precision

Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.

EWNegative Net Change MOHPositive Net Change PDCONegative Net Change AMNNegative Net Change

Zacks Equity Research

Here's Why Investors Should Retain Hologic (HOLX) Stock for Now

Investors are optimistic about Hologic's (HOLX) better-than-expected results and expanded Panther installed base.

MOHPositive Net Change HOLXNegative Net Change PDCONegative Net Change AMNNegative Net Change

Zacks Equity Research

Here's Why You Should Retain Cooper Companies (COO) Stock Now

Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to boost the top line further.

MCKPositive Net Change PDCONegative Net Change COONegative Net Change AMNNegative Net Change

Zacks Equity Research

IDEXX (IDXX) Suffers From Macro Headwinds, Cost Constraints

The strengthening of the rate of exchange for the U.S. dollar relative to other currencies has a negative impact on IDEXX's (IDXX) revenues.

MOHPositive Net Change PDCONegative Net Change IDXXNegative Net Change AMNNegative Net Change

Zacks Equity Research

3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

MCKPositive Net Change PDCONegative Net Change AMNNegative Net Change QDELNegative Net Change

Zacks Equity Research

What's in the Cards for Medtronic (MDT) in Q1 Earnings?

Going by the industry-wide macro trend, we expect Medtronic (MDT) to once again report an adverse effect related to the global supply chain issues in fiscal Q1.

MRKPositive Net Change MDTNegative Net Change MOHPositive Net Change HNGRNo Net Change

Zacks Equity Research

BD's (BDX) Latest Collaboration to Boost Patient Outcome

BD's (BDX) tie-up with Accelerate Diagnostics is expected to strengthen the fight to combat the global threat of antimicrobial resistance, thereby boosting patient care.

LHNegative Net Change BDXPositive Net Change PDCONegative Net Change AMNNegative Net Change

Zacks Equity Research

Implied Volatility Surging for AmerisourceBergen (ABC) Stock Options

Investors need to pay close attention to AmerisourceBergen (ABC) stock based on the movements in the options market lately.

ABCPositive Net Change

Zacks Equity Research

Boston Scientific (BSX) Signs Obsidio-Acquisition Agreement

Boston Scientific's (BSX) latest acquisition will add the FDA-approved GEM technology to its interventional oncology and embolization portfolio.

BSXNegative Net Change MOHPositive Net Change PDCONegative Net Change AMNNegative Net Change

Zacks Equity Research

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS' (STE) robust segmental performance and Cantel Medical buyout.

MOHPositive Net Change PDCONegative Net Change AMNNegative Net Change STENegative Net Change

Zacks Equity Research

Abiomed's (ABMD) Impella Favored by Latest Study Result

Abiomed's (ABMD) Impella-supported high-risk PCI leads to significant improvements in cardiovascular patient outcomes, per latest study.

MCKPositive Net Change ABMDNegative Net Change PDCONegative Net Change AMNNegative Net Change

Zacks Equity Research

LHC Group (LHCG) to Expand Access in Georgia With New Buyout

LHC Group (LHCG) is set to acquire Georgia-based Three Rivers Home Health that will expand its service footprint in 36 counties in the state of Georgia.

UNHPositive Net Change ALKSNegative Net Change LHCGPositive Net Change SWAVNegative Net Change

Zacks Equity Research

Do Options Traders Know Something About Maravai LifeSciences (MRVI) Stock We Don't?

Investors need to pay close attention to Maravai LifeSciences (MRVI) stock based on the movements in the options market lately.

MRVINegative Net Change